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Results (Continued)

Abstract:
Prior work has shown that our bioprinting system can reliably produce human mammary organoids and tumoroids with
high precision. However, this was not previously applied to mouse models, which are also important with respect to
translational research in cancer drug development. To address this, we have produced protocols for the development of
in vitro structures from murine mammary epithelial and tumor cells. Additionally, we assessed the translatability of
both human and murine bioprinted organoids into mouse mammary fat pads over a period of 6 weeks. Our lab found
that our produced organoids are reliable, they can survive in vivo, and meaningfully integrate within host systems.
Therefore, we have demonstrated that our system is adaptable to both human and murine models, as it offers a unique
methodology for in vivo transplantation of human or murine organoids into mice, which can boost research efforts in
cancer therapy research.
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Results
Figure 1 (left): Manually mixed (not bioprinted) 3D
culture of mouse mammary non-tumorigenic and
tumorigenic lines (EPH4, HC11, and ERBB2) at Day
14, at magnifications of 40X, 100X, 200X, and 400X.
Manual mixes failed to form organized, repeatable
structures
that
were
sufficient
for
implantation. This mirrors the findings of Reid et al
(2018), in which human mammary cell lines that
were subjected to manually mixed 3D culture also
failed to produce desirable structures.

Figure 2 (right): In vitro chimeric organoids,
analyzed by fluorescence microscopy (parts A
and B) and by immunohistochemistry (IHC;
parts C and D). A) Linear chimeric organoid
printed from MCF-12A-GFP epithelium and
MMTV-ERBB2-RFP tumoroids. B) Linear
chimeric organoid printed from EPH4-GFP
epithelium and MCF-7-RFP tumoroids. C) IHC
slide of organoid pictured in part A. Cell
nuclei are stained blue with DAPI. D) IHC slide
of organoid pictured in part B. Cell nuclei are
stained blue with DAPI.

These linear organoid structures, one of murine epithelium with human tumoroids and one of murine epithelium
with murine tumoroids, were sturdy and were later implanted into murine mammary fat pads. The fat pads were
harvested after 6 weeks, and examined via H&E and IHC, for presence of the implanted organoids (see Figure 3).

Figure 3 (above): A) Hematoxylin and eosin (H&E) closeup of mammary fat pad section with
organoid implants; darker area shows implants in the form of a cyst. B) H&E closeup of gland
extract with normal area. C) IHC closeup of B, stained for GFP and DAPI. D) Second IHC Closeup of
B, stained for GFP and DAPI. (Bar = 50 µm) IHC guide: DAPI stains blue; GFP stains green.
Organoid implants were found to be detectable 6 weeks after, showing successful integration into
murine mammary fat pads.

Summary and Conclusion:
3D bioprinting demonstrated an ability to organize mouse mammary cells into 3D structures that
can then be optimized for further study. Chimeric organoids were implanted within mice and
survived for 6 weeks, paving the way for follow-up studies in intact, functional organoid
implantation, and follow-up analysis. It is worth reiterating that this is by large a pilot work, but it
allows for more optimizable translational medicine and bioprinting. Future work lies in more
complete animal studies that would aim to address pure organoid structures, with more mice.
Lastly, further molecular diagnostic work is required to understand deeper molecular
mechanisms at play in the long-term viability of implantation studies.
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